SAVAVET launched “nulura” at the Annual Sales Conference of CA Division

The SAVAVET CA business successfully conducted its Annual Sales Conference from 27th March to 2nd April 2025 at the picturesque Ocean Spray Resort, Pondicherry. This event provided an excellent platform for the entire team to connect, exchange insights, and strategize for the upcoming year.

A major highlight of the conference was the official launch of “nulura” — a highly palatable and clinically proven Fluralaner Chewable Tablet, introduced by Mr. Aniruddha Rajurkar, CEO of SAVA Healthcare.

“nulura” promises to be a game-changer in the veterinary parasiticidal industry, offering enhanced relief for dogs suffering from heavy tick infestations.

Throughout the event, our dynamic and committed sales team engaged in strategic discussions and insightful presentations, strengthening internal bonds and fostering a deeper sense of trust and collaboration.

The enthusiasm and dedication displayed during the conference have laid a strong foundation for a year of renewed growth, innovation, and success.

Here’s to achieving new milestones and creating more remarkable memories together in the year ahead!